Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity

NCT03313752 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes Mellitus
Stable Coronary Artery Disease

Interventions

DRUG: Dapagliflozin 10Mg Tab
OTHER: Placebo

Sponsor

Giaccari Andrea